Headache caused by brain metastases of castration-resistant prostate cancer during cabazitaxel therapy

Keitaro Watanabe, Takeo Kosaka, Hiroshi Hongo, Satoshi Tamaki, Mototsugu Oya

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We describe the case of a 55-year-old man who underwent four cycles of cabazitaxel therapy for castration- resistant prostate cancer (CRPC). After the fourth cycle of cabazitaxel, the patient experienced severe headaches. Brain gadolinium (Gd) contrast-enhanced magnetic resonance imaging (MRI) revealed multiple brain metastases. A few days later, the patient suffered impaired consciousness that progressed rapidly. The patient was treated for the symptoms of increased intracranial pressure and underwent whole-brain radiation. One month later, the patient’s consciousness level and headache had improved. Although brain metastases of prostate cancer are rare, the possibility of brain metastases should be considered for prostate cancer patients, especially when a CRPC patient complains of headache. Additionally, even if major conditions such as cerebral hemorrhage are excluded by the use of non-contrast enhanced computed tomography, brain Gd contrast-enhanced MRI should be performed in consideration of the possibility of brain metastases of prostate cancer.

Original languageEnglish
Pages (from-to)65-71
Number of pages7
JournalKeio Journal of Medicine
Volume66
Issue number4
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Castration
Headache
Prostatic Neoplasms
Neoplasm Metastasis
Brain
Gadolinium
Consciousness
Therapeutics
Magnetic Resonance Imaging
Cerebral Hemorrhage
Intracranial Pressure
cabazitaxel
Tomography
Radiation

Keywords

  • Brain metastases
  • Cabazitaxel
  • Gadolinium contrast-enhanced MRI
  • Headache
  • Prostate cancer

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Headache caused by brain metastases of castration-resistant prostate cancer during cabazitaxel therapy. / Watanabe, Keitaro; Kosaka, Takeo; Hongo, Hiroshi; Tamaki, Satoshi; Oya, Mototsugu.

In: Keio Journal of Medicine, Vol. 66, No. 4, 01.01.2017, p. 65-71.

Research output: Contribution to journalArticle

@article{5e3083cbdb454904b4edd13b8e173d17,
title = "Headache caused by brain metastases of castration-resistant prostate cancer during cabazitaxel therapy",
abstract = "We describe the case of a 55-year-old man who underwent four cycles of cabazitaxel therapy for castration- resistant prostate cancer (CRPC). After the fourth cycle of cabazitaxel, the patient experienced severe headaches. Brain gadolinium (Gd) contrast-enhanced magnetic resonance imaging (MRI) revealed multiple brain metastases. A few days later, the patient suffered impaired consciousness that progressed rapidly. The patient was treated for the symptoms of increased intracranial pressure and underwent whole-brain radiation. One month later, the patient’s consciousness level and headache had improved. Although brain metastases of prostate cancer are rare, the possibility of brain metastases should be considered for prostate cancer patients, especially when a CRPC patient complains of headache. Additionally, even if major conditions such as cerebral hemorrhage are excluded by the use of non-contrast enhanced computed tomography, brain Gd contrast-enhanced MRI should be performed in consideration of the possibility of brain metastases of prostate cancer.",
keywords = "Brain metastases, Cabazitaxel, Gadolinium contrast-enhanced MRI, Headache, Prostate cancer",
author = "Keitaro Watanabe and Takeo Kosaka and Hiroshi Hongo and Satoshi Tamaki and Mototsugu Oya",
year = "2017",
month = "1",
day = "1",
doi = "10.2302/kjm.2016-0014-CR",
language = "English",
volume = "66",
pages = "65--71",
journal = "Keio Journal of Medicine",
issn = "0022-9717",
publisher = "Keio University School of Medicine",
number = "4",

}

TY - JOUR

T1 - Headache caused by brain metastases of castration-resistant prostate cancer during cabazitaxel therapy

AU - Watanabe, Keitaro

AU - Kosaka, Takeo

AU - Hongo, Hiroshi

AU - Tamaki, Satoshi

AU - Oya, Mototsugu

PY - 2017/1/1

Y1 - 2017/1/1

N2 - We describe the case of a 55-year-old man who underwent four cycles of cabazitaxel therapy for castration- resistant prostate cancer (CRPC). After the fourth cycle of cabazitaxel, the patient experienced severe headaches. Brain gadolinium (Gd) contrast-enhanced magnetic resonance imaging (MRI) revealed multiple brain metastases. A few days later, the patient suffered impaired consciousness that progressed rapidly. The patient was treated for the symptoms of increased intracranial pressure and underwent whole-brain radiation. One month later, the patient’s consciousness level and headache had improved. Although brain metastases of prostate cancer are rare, the possibility of brain metastases should be considered for prostate cancer patients, especially when a CRPC patient complains of headache. Additionally, even if major conditions such as cerebral hemorrhage are excluded by the use of non-contrast enhanced computed tomography, brain Gd contrast-enhanced MRI should be performed in consideration of the possibility of brain metastases of prostate cancer.

AB - We describe the case of a 55-year-old man who underwent four cycles of cabazitaxel therapy for castration- resistant prostate cancer (CRPC). After the fourth cycle of cabazitaxel, the patient experienced severe headaches. Brain gadolinium (Gd) contrast-enhanced magnetic resonance imaging (MRI) revealed multiple brain metastases. A few days later, the patient suffered impaired consciousness that progressed rapidly. The patient was treated for the symptoms of increased intracranial pressure and underwent whole-brain radiation. One month later, the patient’s consciousness level and headache had improved. Although brain metastases of prostate cancer are rare, the possibility of brain metastases should be considered for prostate cancer patients, especially when a CRPC patient complains of headache. Additionally, even if major conditions such as cerebral hemorrhage are excluded by the use of non-contrast enhanced computed tomography, brain Gd contrast-enhanced MRI should be performed in consideration of the possibility of brain metastases of prostate cancer.

KW - Brain metastases

KW - Cabazitaxel

KW - Gadolinium contrast-enhanced MRI

KW - Headache

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85039793252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039793252&partnerID=8YFLogxK

U2 - 10.2302/kjm.2016-0014-CR

DO - 10.2302/kjm.2016-0014-CR

M3 - Article

C2 - 28392539

AN - SCOPUS:85039793252

VL - 66

SP - 65

EP - 71

JO - Keio Journal of Medicine

JF - Keio Journal of Medicine

SN - 0022-9717

IS - 4

ER -